Astellas Research Institute of America

Astellas Research Institute of America (ARIA) is a specialized research subsidiary of the global pharmaceutical company Astellas Pharma, focused on the discovery of novel therapeutics for central nervous system (CNS) disorders. Based in Skokie, Illinois, the institute serves as a primary hub for the parent company's neuroscience R&D, emphasizing psychiatric and neurological conditions such as schizophrenia and treatment-resistant depression. ARIA utilizes advanced drug discovery platforms to identify and validate new biological targets, particularly in the areas of synaptic plasticity and neurocircuitry. The institute's work is integral to the broader Astellas strategy of turning innovative science into value for patients with high unmet medical needs. By leveraging deep expertise in medicinal chemistry and neurobiology, ARIA bridges the gap between early-stage discovery and clinical development within the Astellas global network.